Market Overview:
The global Acute Ischemic Stroke (AIS) Market is estimated to be valued at US$ 8,517.0 million in 2021 and is expected to exhibit a CAGR of 4.0% over the forecast period 2021-2028, as highlighted in a new report published by Coherent Market Insights. AIS refers to a sudden lack of blood flow to the brain due to a blockage in one of the arteries, leading to neurological damage and potentially life-threatening complications. The market offers various ... Read more
Acute ischemic strokes (AIS) occur when blood flow to an area of the brain is blocked by a clot in a blood vessel leading to brain cell damage. Tissue plasminogen activator (tPA) therapy aims to treat AIS by dissolving clots through fibrinolytic medications that help break down blood clots. tPA therapy must be administered as soon as possible, ideally within 3-4.5 hours of stroke onset. However, timely management of neurovascular conditions like AIS remains a challenge.
